Reported Reactions

Devices › Prosthesis, breast, noninflatable, internal, silicone gel-filled

Device brand name · Silicone gel breast implant

Sientra Opus Silicone Gel Breast Implant: medical device reports filed with FDA

4,613 reports name it, 2019–2023. Manufacturer given most often on reports: Sientra. Product code FTR.

4,613
device reports naming the brand
0% of all MAUDE reports · about 644 a year
0
reports, 12 months to August 2026
0 in the 12 months before
0%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,613 reports that name the brand "Sientra Opus Silicone Gel Breast Implant" (silicone gel breast implant), received between May 2019 and March 2023; the manufacturer given most often on reports is Sientra. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all prosthesis, breast, noninflatable, internal, silicone gel-filled reports (product code FTR) death is recorded in 0.1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are patient device interaction problem (29.1%), material rupture (12.5%) and gel leak (8.6%). The patient problems coded most often are capsular contracture, rupture and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0113226Sep 2021: 150Oct 2021: 122Nov 2021: 187Dec 2021: 1642022Jan 2022: 154Feb 2022: 131Mar 2022: 133Apr 2022: 188May 2022: 155Jun 2022: 135Jul 2022: 128Aug 2022: 169Sep 2022: 175Oct 2022: 226Nov 2022: 167Dec 2022: 1592023Jan 2023: 185Feb 2023: 160Mar 2023: 7Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

09601,9202019: 58720192020: 70820202021: 1,04620212022: 1,92020222023: 3522023

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,611
Malfunction0%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%4,613
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 231,877 reports carrying product code FTR. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Patient device interaction problem1,34229.1%2.7%
Material rupture57812.5%42.7%
Gel leak3988.6%1.9%
Patient-device incompatibilitythe device did not suit the patient1944.2%6.6%
Insufficient device problem information400.9%0.2%
Material deformation180.4%0.2%
Malposition of device150.3%0.5%
Material protrusion/extrusion150.3%0%
Biocompatibility110.2%0%
Leak/splashthe device leaked80.2%0.3%
Positioning failure70.2%0%
Unintended deflation70.2%0%
Device dislodged or dislocated60.1%0%
Positioning problem50.1%0%
Inadequacy of device shape and/or size30.1%0%
Burst container or vessel20%0%
Contamination20%0%
Migration or expulsion of device20%0.2%
Structural problem20%0%
Unintended ejection20%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Capsular contracturescar tissue tightening around an implant3,38573.4%
Rupturethe device burst4349.4%
Seromaa collection of fluid under the skin1162.5%
Failure of implant621.3%
Painpain, site not specified441%
Fatiguetiredness290.6%
Deformity/ disfigurement260.6%
Headachehead pain170.4%
Arthralgiajoint pain160.3%
Hair loss160.3%
Anaplastic large cell lymphoma150.3%
Inflammationinflammation150.3%
Memory loss/impairment140.3%
Swellingswelling140.3%
Breast implant associated anaplastic large cell lymphoma (bia alcl)130.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSientra Opus Silicone Gel Breast ImplantProduct code FTRAll MAUDE reports
Reports4,613231,87726,136,888
Share of that pool—2%0%
Classified as death, per 1,000 reports019
Classified as injury100%97.7%36.2%
Classified as malfunction0%1.6%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FTR

BrandReportsLatest 12 monthsClassified as death
MENTOR MemoryGel Breast Implant57,7717,7080%
Inspira Smooth Silicone Gel Filled Breast Implant35,6346,7820%
Inspira Textured Silicone Gel Filled Breast Implant24,7952,7660%
Style 410 Cohesive Silicone Gel Filled Breast Implant15,2871,8410.1%
Style 15 Silicone Gel Filled Breast Implant9,5671,5290.1%
Style 20 Silicone Gel Filled Breast Implant6,3689810.1%
Sientra Silicone Gel Breast Implants6,0141,6820%
Style 115 Silicone Gel Filled Breast Implant5,7105460%
Unknown Gel Implants5,3377030%
UNK Gel Breast Implant5,3027820.4%
MENTOR MemoryGel Xtra Breast Implant4,9101,3870%
Inspira Smooth Cohesive Silicone Gel Filled Breast Implant4,6361,0760%
Style 110 Silicone Gel Filled Breast Implant3,3642790%
Style 10 Silicone Gel Filled Breast Implant3,3534790.1%
Style 120 Silicone Gel Filled Breast Implant2,8812120.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Sientra Opus Silicone Gel Breast Implant reports

How many FDA reports name Sientra Opus Silicone Gel Breast Implant?

4,613 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

patient device interaction problem (29.1%), material rupture (12.5%), gel leak (8.6%), patient-device incompatibility (4.2%) and insufficient device problem information (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Sientra Opus Silicone Gel Breast Implant was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.